ACCURUN 140 RUBELLA IGG POSITIVE CONTROL

ACCURUN 140 RUBELLA IGG POSITIVE CONTROL is an FDA 510(k)-cleared medical device (K972986) manufactured by Boston Biomedica, Inc.. This device is classified under the Clinical Chemistry specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on October 7, 1997. Regulation: 8.